Emcure Pharmaceuticals Q1 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: Biotechnology & Drugs
BSE
1,480.10
-18.00 (-1.20%)
-18.00 (-1.20%)Volume693.00
Updated: Thu 12 Feb, 2026 | 09:40:38
NSE
1,483.30-15.50 (-1.03%)
-15.50 (-1.03%)Volume12.48 K
Updated: Thu 12 Feb, 2026 | 09:31:18
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,799.60 | 1,833.54 | -1.85% | 1,572.41 | 14.45% |
| Depreciation/ Amortization | 99.46 | 96.84 | 2.70% | 93.59 | 6.27% |
| Operating Income | 300.93 | 282.71 | 6.45% | 242.73 | 23.98% |
| Net Income | 206.95 | 188.96 | 9.52% | 144.08 | 43.64% |
| Other Operating Expenses Total | 501.16 | 460.85 | 8.75% | 445.32 | 12.54% |
| Net Income Before Taxes | 290.76 | 260.61 | 11.57% | 207.41 | 40.19% |
| Total Revenue | 2,100.54 | 2,116.25 | -0.74% | 1,815.14 | 15.72% |
| Selling/ General/ Admin Expenses Total | 393.47 | 373.37 | 5.39% | 350.40 | 12.29% |
| Diluted Normalized EPS | 11.06 | 10.39 | 6.42% | 7.95 | 39.07% |